Genetic discovery could improve treatment of colorectal cancer

by Rémi Carlier,Ecole Polytechnique Federale de LausannePOU5F1B differs from OCT4. a Representative immunofluorescence–confocal microscopy of POU5F1B-HA overexpressing SW480 cells, with DAPI in

Updated on: December 25,2023

Genetic discovery could improve treatment of colorectal cancer

by Rémi Carlier,Ecole Polytechnique Federale de LausannePOU5F1B differs from OCT4. a Representative immunofluorescence–confocal microscopy of POU5F1B-HA overexpressing SW480 cells, with DAPI in

Updated on:December 25,2023

Heterogeneity of liver cancer cells helps explain tumor progression in patients

byThe Mount Sinai HospitalCredit: CC0 Public DomainMany liver cancer tumors contain a highly diverse set of cells, a phenomenon known as intra-tumor heterogeneity that can significantly affect t

Updated on: December 20,2023

Heterogeneity of liver cancer cells helps explain tumor progression in patients

byThe Mount Sinai HospitalCredit: CC0 Public DomainMany liver cancer tumors contain a highly diverse set of cells, a phenomenon known as intra-tumor heterogeneity that can significantly affect t

Updated on:December 20,2023

A new therapeutic target turns the immune system against lymphoma

by Ecole Polytechnique Federale de LausanneCredit: CC0 Public DomainNon-Hodgkin's lymphoma (NHL) is a group of cancers that originate in the lymph nodes and affect white blood cells of the im

Updated on: March 25,2024

A new therapeutic target turns the immune system against lymphoma

by Ecole Polytechnique Federale de LausanneCredit: CC0 Public DomainNon-Hodgkin's lymphoma (NHL) is a group of cancers that originate in the lymph nodes and affect white blood cells of the im

Updated on:March 25,2024

New treatment for a rare and aggressive cancer improves survival rates in breakthrough clinical trial

FEBRUARY 15, 2024byQueen Mary, University of LondonCredit: Pixabay/CC0 Public DomainAn innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but

Updated on: March 29,2024

New treatment for a rare and aggressive cancer improves survival rates in breakthrough clinical trial

FEBRUARY 15, 2024byQueen Mary, University of LondonCredit: Pixabay/CC0 Public DomainAn innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but

Updated on:March 29,2024

Taking a closer look at eye cancer: Research offers new insight into high rate of metastasis

byEdith Cowan UniversityCredit: Marc Schulte from PexelsNew research from Edith Cowan University (ECU) is one step closer to understanding why uveal melanoma, the deadliest form of eye cancer, h

Updated on: August 01,2024

Taking a closer look at eye cancer: Research offers new insight into high rate of metastasis

byEdith Cowan UniversityCredit: Marc Schulte from PexelsNew research from Edith Cowan University (ECU) is one step closer to understanding why uveal melanoma, the deadliest form of eye cancer, h

Updated on:August 01,2024

Study describes treatment of secondary CNS involvement by aggressive lymphomas

by Sylvester Comprehensive Cancer CenterHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Some patients with aggressive lymphomas

Updated on: June 28,2024

Study describes treatment of secondary CNS involvement by aggressive lymphomas

by Sylvester Comprehensive Cancer CenterHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Some patients with aggressive lymphomas

Updated on:June 28,2024

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval

Updated on: January 04,2024

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval

Updated on:January 04,2024

New genetic test for pancreatic cancer outperforms current guidelines

by University of PittsburghCredit: Pixabay/CC0 Public DomainA molecular test called PancreaSeq accurately classifies pancreatic cysts as potentially cancerous or benign, according to a large, mul

Updated on: January 30,2024

New genetic test for pancreatic cancer outperforms current guidelines

by University of PittsburghCredit: Pixabay/CC0 Public DomainA molecular test called PancreaSeq accurately classifies pancreatic cysts as potentially cancerous or benign, according to a large, mul

Updated on:January 30,2024

Lower prostate cancer screening rates associated with subsequent increase in advanced cancers

byAmerican Society for Radiation OncologyProstate cancer cells. Credit: NIH Image GalleryIn the face of conflicting evidence over the risks and benefits of routine prostate cancer screenings, a

Updated on: December 26,2023

Lower prostate cancer screening rates associated with subsequent increase in advanced cancers

byAmerican Society for Radiation OncologyProstate cancer cells. Credit: NIH Image GalleryIn the face of conflicting evidence over the risks and benefits of routine prostate cancer screenings, a

Updated on:December 26,2023

Experts reach consensus on gene therapy carcinogenicity risks

byMary Ann Liebert, IncCredit: CC0 Public DomainAnarticlein the journalHuman Gene Therapydescribes the consensus reached by invited experts who participated in a meeting

Updated on: September 03,2024

Experts reach consensus on gene therapy carcinogenicity risks

byMary Ann Liebert, IncCredit: CC0 Public DomainAnarticlein the journalHuman Gene Therapydescribes the consensus reached by invited experts who participated in a meeting

Updated on:September 03,2024

New therapeutic strategy for metastatic prostate cancer patients resistant to standard treatment

FEBRUARY 2, 2024 Editors' notesby Germans Trias i Pujol Research InstituteCredit: Unsplash/CC0 Public DomainA team of researchers from the Badalona Applied Research Group in Oncology (B·ARGO) and

Updated on: March 15,2024

New therapeutic strategy for metastatic prostate cancer patients resistant to standard treatment

FEBRUARY 2, 2024 Editors' notesby Germans Trias i Pujol Research InstituteCredit: Unsplash/CC0 Public DomainA team of researchers from the Badalona Applied Research Group in Oncology (B·ARGO) and

Updated on:March 15,2024

Research shows that DOPA protects against melanoma

byPerelman School of Medicine at the University of PennsylvaniaHistologic characterization of representative orthotopic skin and resulting tumors, including MC and proliferation markers MITF (re

Updated on: January 22,2024

Research shows that DOPA protects against melanoma

byPerelman School of Medicine at the University of PennsylvaniaHistologic characterization of representative orthotopic skin and resulting tumors, including MC and proliferation markers MITF (re

Updated on:January 22,2024